These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An Enhanced Pre- and Postnatal Development Study in Cynomolgus Monkeys with Tabalumab: A Human IgG4 Monoclonal Antibody. Breslin WJ, Hilbish KG, Martin JA, Halstead CA, Newcomb DL, Chellman GJ. Birth Defects Res B Dev Reprod Toxicol; 2015 Jun; 104(3):100-16. PubMed ID: 26195230 [Abstract] [Full Text] [Related]
9. Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an alpha4 integrin inhibitor. Wehner NG, Shopp G, Osterburg I, Fuchs A, Buse E, Clarke J. Birth Defects Res B Dev Reprod Toxicol; 2009 Apr; 86(2):144-56. PubMed ID: 19283860 [Abstract] [Full Text] [Related]
13. Embryo/fetal development in cynomolgus monkeys exposed to natalizumab, an alpha4 integrin inhibitor. Wehner NG, Shopp G, Oneda S, Clarke J. Birth Defects Res B Dev Reprod Toxicol; 2009 Apr; 86(2):117-30. PubMed ID: 19278014 [Abstract] [Full Text] [Related]
14. Assessment of ixekizumab, an interleukin-17A monoclonal antibody, for potential effects on reproduction and development, including immune system function, in cynomolgus monkeys. Clarke DO, Hilbish KG, Waters DG, Newcomb DL, Chellman GJ. Reprod Toxicol; 2015 Dec; 58():160-73. PubMed ID: 26482726 [Abstract] [Full Text] [Related]
15. Developmental toxicity assessment of tanezumab, an anti-nerve growth factor monoclonal antibody, in cynomolgus monkeys (Macaca fascicularis). Bowman CJ, Evans M, Cummings T, Oneda S, Butt M, Hurst S, Gremminger JL, Shelton D, Kamperschroer C, Zorbas M. Reprod Toxicol; 2015 Jun; 53():105-18. PubMed ID: 25461901 [Abstract] [Full Text] [Related]
16. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid. Tzimas G, Nau H, Hendrickx AG, Peterson PE, Hummler H. Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347 [Abstract] [Full Text] [Related]
18. Use of barusiban in a novel study design for evaluation of tocolytic agents in pregnant and neonatal monkeys, including behavioural and immunological endpoints. Rasmussen AD, Nelson JK, Chellman GJ, Golub M, McAnulty PA. Reprod Toxicol; 2007 Jun; 23(4):471-9. PubMed ID: 17337159 [Abstract] [Full Text] [Related]
19. Placental and Fetal Effects of Onartuzumab, a Met/HGF Signaling Antagonist, When Administered to Pregnant Cynomolgus Monkeys. Prell RA, Dybdal N, Arima A, Chihaya Y, Nijem I, Halpern W. Toxicol Sci; 2018 Sep 01; 165(1):186-197. PubMed ID: 29893934 [Abstract] [Full Text] [Related]
20. Placental transfer of a fully human IgG2 monoclonal antibody in the cynomolgus monkey, rat, and rabbit: a comparative assessment from during organogenesis to late gestation. Moffat GJ, Retter MW, Kwon G, Loomis M, Hock MB, Hall C, Bussiere J, Lewis EM, Chellman GJ. Birth Defects Res B Dev Reprod Toxicol; 2014 Apr 01; 101(2):178-88. PubMed ID: 24753333 [Abstract] [Full Text] [Related] Page: [Next] [New Search]